340 related articles for article (PubMed ID: 33557878)
1. Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Holland AJ; Driscoll DJ;
Orphanet J Rare Dis; 2021 Feb; 16(1):69. PubMed ID: 33557878
[TBL] [Abstract][Full Text] [Related]
2. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
3. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
4. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
Endocrine; 2012 Apr; 41(2):191-9. PubMed ID: 22081257
[TBL] [Abstract][Full Text] [Related]
6. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
Höybye C; Hilding A; Marcus C; Thorén M
Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
9. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.
Cadoudal T; Buléon M; Sengenès C; Diene G; Desneulin F; Molinas C; Eddiry S; Conte-Auriol F; Daviaud D; Martin PG; Bouloumié A; Salles JP; Tauber M; Valet P
Int J Obes (Lond); 2014 Sep; 38(9):1234-40. PubMed ID: 24406482
[TBL] [Abstract][Full Text] [Related]
10. Current status of growth hormone therapy in Prader-Willi syndrome.
Höybye C
Expert Rev Endocrinol Metab; 2013 Nov; 8(6):529-536. PubMed ID: 30736137
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
Grugni G; Marzullo P
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
[TBL] [Abstract][Full Text] [Related]
13. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
[TBL] [Abstract][Full Text] [Related]
14. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone treatment for Prader-Willi syndrome: A review.
Yang X
Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
Höybye C; Hilding A; Jacobsson H; Thorén M
Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
[TBL] [Abstract][Full Text] [Related]
19. Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.
Damen L; Grootjen LN; Donze SH; Juriaans AF; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2020 Oct; 93(4):439-448. PubMed ID: 32609902
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome and growth hormone deficiency.
Aycan Z; Baş VN
J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]